Heron Therapeutics | HRTX - 贸易债权人

金融业

USD

USD 246.22M

现金及等价物

USD 26.12M

USD 11.12M

USD 228.98M

USD 90.52M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 9.14M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 60.1M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.97M

应收帐款人

USD 89.59M

	贸易债权人	更改		日
ALKERMES	USD 102.36M		5.59M	2026-03
Alnylam Pharmaceuticals	USD 126.63M		10.91M	2026-03
Amarin	USD 48.15M		2.8M	2026-03
ANI Pharmaceuticals	USD 69.69M		7.11M	2026-03
Anika Therapeutics	USD 6.34M		298K	2026-03
Arrowhead Research	USD 30.75M		2.19M	2026-03
Eisai	JPY 75.89B		9.6B	2026-03
Emergent BioSolutions	USD 112.2M		500K	2023-12
Esperion Therapeutics	USD 68.41M		3.34M	2026-03
GlaxoSmithKline	GBP 14.34B		1.05B	2026-03
Heron Therapeutics	USD 8.97M		24K	2026-03
Insmed	USD 73.38M		6.53M	2026-03
Ligand Pharmaceuticals	USD 37.11M		33.87M	2026-03
Merck	USD 3.86B		541M	2026-03
Nektar Therapeutics	USD 10.77M		4.79M	2025-12
Neurocrine Biosciences	USD 691.3M		145.8M	2026-03
Omeros	USD 8.84M		4.42M	2025-06
Pacira	USD 14.01M		1.14M	2026-03
Regeneron Pharmaceuticals	USD 1.03B		4.81B	2026-03
Roche Holding	CHF 5.78B		1.27B	2025-12
Sangamo BioSciences	USD 10.74M		7.46M	2025-06
Ultragenyx Pharmaceutical	USD 42M		11M	2026-03
Veracyte	USD 6.91M		2.32M	2026-03
Vertex Pharmaceuticals	USD 3.47B		40.6M	2026-03